Effects of Aging, Disease and the Environment on the Pulmonary Surfactant System

The Lung: Development, Aging and The Environment

Volumn , Issue , 2003, Pages 364-375

  Orgeig, Sandra ^a   Daniels, Christopher B ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942278679     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1016/B978-012324751-3/50061-9     Document Type: Article

References (158)

1. Janssens JP, Pache JC, Nicod LP Physiological changes in respiratory function associated with ageing. Eur. Respir. J. 1999, 13:197-205.
2. Ueda T, Cheng G, Kuroki Y, et al. Effects of aging on surfactant forms in rats. Eur. Respir. J. 2000, 15:80-84.
3. Clercx C, Venker van Haagen AJ, den Breejen JN, et al. Effects of age and breed on the phospholipid composition of canine surfactant. Lung 1989, 167:351-357.
4. Kato S, Takahashi K The mechanism of age-related change in lung elastic recoil pressure. Nihon Kyobu Shikkan Gakkai Zasshi 1993, 30:175-181.
5. Shimura S, Maeda S, Takismima T Giant lamellar bodies in alveolar type II cells of rats exposed to a low concentration of ozone. Respiration 1984, 46:303-309.
6. Rebello CM, Jobe AH, Eisele JW, et al. Alveolar and tissue surfactant pool sizes in humans. Am. J. Respir. Crit. Care Med. 1996, 154:625-628.
7. Turner MJ, Mier CM, Spina RJ, et al. Effects of age and gender on cardiovascular responses to phenylephrine. J. Gerontol. 1999, 54A:M17-M24.
8. Gaballa MA, Eckhart AD, Koch WJ, et al. Vascular beta-adrenergic receptor adenylyl cyclase system in maturation and aging. J. Mol. Cell. Cardiol. 2000, 32:1745-1755.
9. Bell C, Seals DR, Monroe MB, et al. Tonic sympathetic support of metabolic rate is attenuated with age, sedentary lifestyle, and female sex in healthy adults. J. Clin. Endocrinol. Metab. 2001, 86:4440-4444.
10. Tsukada H, Kakiuchi T, Nishiyama S, et al. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzidale in the brains of conscious monkeys. Synapse 2001, 41:248-257.
11. Gyetko MR, Toews GB Immunology of the aging lung. Clin. Chest Med. 1993, 14:379-391.
12. Wallace WA, Gillooly M, Lamb D Age related increase in the intra-alveolar macrophage population of non-smokers. Thorax 1993, 48:668-669.
13. Mancuso P, McNish RW, Peters Golden M, et al. Evaluation of phagocytosis and arachidonate metabolism by alveolar macrophages and recruited neutrophils from F344xBN rats of different ages. Mech. Ageing Dev. 2001, 122:1899-1913.
14. Goodman BE Characteristics and regulation of active transport in lungs from young and aged mammals. Prog. Clin. Biol. Res. 1988, 258:263-274.
15. Braga FJ, Manco JC, Souza JF, et al. Age-related reduction in 99T cm-DTPA alveolar-capillary clearance in normal humans. Nucl. Med. Commun. 1996, 17:971-974.
16. Uejima Y, Fukuchi Y, Nagase T, et al. Influences of inhaled tobacco smoke on the senescence accelerated mouse (SAM). Eur. Respir. J. 1990, 3:1029-1036.
17. Uejima Y, Fukuchi Y, Teramoto S, et al. Age changes in visceral content of glutathione in the senescence accelerated mouse (SAM). Mech. Ageing Dev. 1993, 67:129-139.
18. Uejima Y, Fukuchi Y, Nagase T, et al. A new murine model of aging lung: the senescence accelerated mouse (SAM)-P. Mech. Ageing Dev. 1991, 61:223-236.
19. Griese M Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 1999, 13:1455-1476.
20. Devendra G, Spragg RG Lung surfactant in subacute pulmonary disease. Respir. Res. 2002, 3:19.
21. Weinacker AB, Vaszar LT Acute respiratory distress syndrome: physiology and new management strategies. Annu. Rev. Med. 2001, 52:221-237.
22. Doyle IR, Nicholas TE, Bersten AD Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability. Clin. Exp. Pharmacol. Physiol. 1999, 26:185-197.
23. Hallman M, Spragg R, Harrell JH, et al. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest. 1982, 70:673-683.
24. Bredenberg CE, Paskanik AM, Nieman GF High surface tension pulmonary edema. J. Surg. Res. 1983, 34:515-523.
25. Pison U, Seeger W, Buchhorn R, et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 1989, 140:1033-1039.
26. Pison U, Obertacke U, Brand M, et al. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J. Trauma 1990, 30:19-26.
27. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 1991, 88:1976-1981.
28. Pison U, Obertacke U, Seeger W, et al. Surfactant protein A (SP-A) is descreased in acute parenchymal lung injury associated with polytrauma. Eur. J. Clin. Invest. 1992, 22:712-718.
29. Veldhuizen RA, McCaig LA, Akino T, et al. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1995, 152:1867-1871.
30. Gunther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 1996, 153:176-184.
31. Lewis JF, Jobe AH Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1993, 147:218-233.
32. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1997, 155:1309-1315.
33. Hafner D, Germann PG Dexamethasone enhances the activity of rSP-C surfactant but not of exosurf in a rat model of the acute lung injury. J. Pharmacol. Toxicol. Meth. 1999, 42:39-48.
34. Spragg RG, Smith RM, Harris K, et al. Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury. J. Appl. Physiol. 2000, 88:674-681.
35. Quintero OA, Wright JR Clearance of surfactant lipids by neutrophils and macrophages isolated from the acutely inflamed lung. Am. J. Physiol. 2002, 282:L330-L339.
36. Lewis JF, Veldhuizen R, Possmayer F, et al. Altered alveolar surfactant is an, early marker of acute lung injury in septic adult sheep. Am. J. Respir. Crit. Care Med. 1994, 150:123-130.
37. Raymondos K, Leuwer M, Haslam PL, et al. Compsotional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis. Crit. Care Med. 1999, 27:82-89.
38. Arbibe L, Koumanov K, Vial D, et al. Generation of lysophospholipids from surfactant in acute lung injury, is mediated by type-II phospholipase A2 and inhibited, by a direct surfactant protein A-phospholipase A2 protein interaction. J. Clin. Invest. 1998, 102:1152-1160.
39. Holm BA, Keicher L, Liu MY, et al. Inhibition of pulmonary surfactant function by phospholipases. J. Appl. Physiol. 1991, 71:317-321.
40. Niewoehner DE, Rice K, Sinha AA, et al. Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium. J. Appl. Physiol. 1987, 63:1979-1986.
41. Lindahl M, Hede AR, Tagesson C Lysophosphatidylcholine increases airway and capillary permeability in the isolated perfused rat lung. Exp. Lung Res. 1986, 11:1-12.
42. Keough KMW, Parsons CS, Tweeddale MG Interactions between plasma proteins and pulmonary surfactant: pulsating bubble studies. Can. J. Physiol. Pharmacol. 1989, 67:663-668.
43. Friedrich W, Schmalisch G, Stevens PA, et al. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins. Eur. J. Med. Res. 2000, 5:277-282.
44. Warriner HE, Ding J, Waring AJ, et al. A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants. Biophys. J. 2002, 82:835-842.
45. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am. J. Respir. Crit. Care Med. 1999, 160:1843-1850.
46. Ingenito EP, Mora R, Cullivan M, et al. Decreased surfactant protein-B expression and surfactant dysfunction in a murine model of acute lung injury. Am. J. Respir. Cell Mol. Biol. 2001, 25:35-44.
47. McDowell SA, Gammon K, Bachurski CJ, et al. Differential gene expression in the initiation and progression of nickel-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 2000, 23:466-474.
48. Leikauf GD, McDowell SA, Wesselkamper SC, et al. Acute lung injury: functional genomics and genetic susceptibility. Chest 2002, 121:70s-75s.
49. Baker CS, Evans TW, Randle BJ, et al. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999, 353:1232-1237.
50. Hohlfeld J, Fabel H, Hamm H The role of pulmonary surfactant in obstructive airways disease. Eur. Respir. J. 1997, 10:482-491.
51. Hohlfeld JM The role of surfactant in asthma. Respir. Res. 2002, 3:4.
52. Liu M, Wang L, Enhorning G Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin. Exp. Allergy 1995, 25:1053-1060.
53. Hohlfeld JM, Ahlf K, Enhorning G, et al. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am. J. Respir. Crit. Care Med. 1999, 159:1803-1809.
54. Cheng G, Ueda T, Sugiyama K, et al. Compositional and functional changes of pulmonary surfactant in a guinea-pig model of chronic asthma. Respir. Med. 2001, 95:180-186.
55. Liu M, Wang L, Li E, et al. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin. Exp. Allergy 1996, 26:270-275.
56. Kurashima K, Fujimura M, Tsujiura M, et al. Effect of surfactant inhalation on allergic bronchoconstriction in guinea pigs. Clin. Exp. Allergy 1997, 27:337-342.
57. Kurashima K, Ogawa H, Ohka T, et al. A pilot study of surfactant inhalation in the treatment of asthmatic attack. Arerugi 1991, 40:160-163.
58. Griese M, Birrer P, Demirsoy A Pulmonary surfactant in cystic fibrosis. Eur. Respir. J. 1997, 10:1983-1988.
59. von Bredow C, Birrer P, Griese M Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur. Respir. J. 2001, 17:716-722.
60. Postle AD, Mander A, Reid KB, et al. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 1999, 20:90-98.
61. deMello DE, Lin Z Pulmonary alveolar proteinosis: a review. Pediatr. Pathol. Mol. Med. 2001, 20:413-432.
62. Trapnell BC, Whitsett JA Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu. Rev. Physiol. 2002, 64:775-802.
63. Doyle IR, Davidson KG, Barr HA, et al. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am. J. Respir. Crit. Care Med. 1998, 157:658-664.
64. Honda Y, Kataoka K, Hayashi H, et al. Alterations of acidic phospholipids in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Clin. Chim. Acta 1989, 181:11-18.
65. Dockery DW, Pope CA, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N. Engl. J. Med. 1993, 329:1753-1759.
66. Schwartz J Air pollution and daily mortality. A review and meta analysis. Environ. Res. 1994, 64:36-52.
67. Pope CAI, Thun MJ, Namboori MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am. J. Respir. Crit. Care Med. 1995, 151:669-674.
68. Fishbein L Sources, nature and levels of air pollutants. Indoor and Outdoor Air Pollution and Human Cancer 1993, Springer-Verlag, Berlin Heidelberg, Germany. L. Tomatis (Ed.).
69. Hanna LA, Frank R, Scherer PW Absorption of soluble gases and vapours in the respiratory system. Respiratory Physiology-An Analytical Approach 1989, 277-316. Marcel Dekker, Basel. H.K. Chang, M. Paiva (Eds.).
70. Lippmann M Regional deposition of particles in the human respiratory tract. Handbook of Physiology. Section 9. Reactions to Environmental Agents 1977, 213-232. American Physiological Society, Maryland. D.H.K. Lee (Ed.).
71. Kim CS, Kang TC Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway diseases. Am. J. Respir. Crit. Care Med. 1997, 155:899-905.
72. Conway JH, Moore E, Fleming JS, et al. Three dimensional imaging of lung deposition from nebuliser in moderate/severe asthmatics. Am. J. Respir. Crit. Care Med. 1998, 157:A456.
73. Ultman JS Transport and uptake of inhaled gases. Air Pollution, the Automobile, and Public Health 1988, 323-366. National Academy Press, Washington, DC. A.Y. Watson, R.R. Bates, D. Kennedy (Eds.).
74. Warheit DB Interspecies comparisons of lung responses to inhaled particles and gases. CRC Crit. Rev. Toxicol. 1989, 20:1-29.
75. Müller B, Seifart C, Barth PJ Effect of air pollutants on the pulmonary surfactant system. Eur. J. Clin. Invest. 1998, 28:762-777.
76. Norman V, Keith CH Nitrogen oxides in tobacco smoke. Nature 1965, 205:915-916.
77. Arner EC, Rhoades RA Long-term nitrogen dioxide exposure: effects on lung lipids and mechanical properties. Arch. Environ. Health 1973, 26:156-160.
78. Müller B, von Wichert P Effect of nitrogen dioxide inhalation on surfactant phosphatidylcholine synthesis in rat alveolar type II cells. Biochem. Biophys. Acta 1993, 1170:38-43.
79. Haddad IY, Crow JP, Hu P, et al. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am. J. Physiol. 1994, 267:L242-L249.
80. Dowell AR, Kilburn KH, Pratt PC Short-term exposure to nitrogen dioxide. Effects on pulmonary ultrastructure, compliance, and the surfactant system. Arch. Intern. Med. 1971, 128:74-80.
81. Leung HW Effect of nitrogen dioxide exposure on rat lung lipids. Res. Commun. Chem. Pathol. Pharmacol. 1983, 40:519-522.
82. Müller B, Barth P, von Wichert P Structural and functional impairment of surfactant protein A after exposure to nitrogen dioxide in rats. Am. J. Physiol. 1992, 263:L177-L184.
83. Evans MJ, Cabral-Anderson LJ, Freeman G Role of the Clara cell in renewal of the bronchiolar epithelium. Lab. Invest. 1978, 38:648-653.
84. Robinson FR, Runnels LJ, Conrad DA, et al. Pathologic response of the lung to irritant gases. Vet. Hum. Toxicol. 1990, 32:569-572.
85. 2 in the rat and hamster. Br. J. Exp. Pathol. 1985, 66:193-204.
86. 2 as markers of altered surfactant metabolism. Lung 1994, 172:61-72.
87. 2. Exp. Mol. Pathol. 1975, 22:142-150.
88. 3. Lab. Invest. 1976, 35:246-257.
89. 2 by AgNOR-analysis. Exp. Toxicol. Pathol. 1994, 46:335-342.
90. Barth PJ, Uhlarik S, Bittinger A, et al. Diffuse alveolar damage in the rat lung after short and long term exposure to nitrogen dioxide. Pathol. Res. Pract. 1994, 190:33-41.
91. Chang LY, Graham JA, Miller FJ, et al. Effects of subchronic inhalation of low concentrations of nitrogen dioxide. I. The proximal alveolar region of juvenile and adult rats. Toxicol. Appl. Pharmacol. 1986, 83:45-61.
92. Sagai M, Arakawa K, Ichinose T, et al. Biochemical effects on combined gases of nitrogen dioxide and ozone. I. Species differences of lipid peroxides and phospholipids in lungs. Toxicology 1987, 46:251-265.
93. Ichinose T, Sagai M Biochemical effects of combined gases of nitrogen dioxide and ozone. III. Synergistic effects on lipid peroxidation and antioxidative protection systems in the lungs of rats and guinea pigs. Toxicology 1989, 59:259-270.
94. Sagai M, Ichinose T Biochemical effects of combined gases of nitrogen dioxide and ozone. IV. Changes of lipid peroxidation and antioxidative protection systems in rat lungs upon life span exposure. Toxicology 1991, 66:121-132.
95. Putman E, Boere AJ, van Bree L, et al. Pulmonary surfactant subtype metabolism is altered after short-term ozone exposure. Toxicol. Appl. Pharmacol. 1995, 134:132-138.
96. Putman E, Liese W, Voorhout WF, et al. Short-term ozone exposure affects the surface activity of pulmonary surfactant. Toxicol. Appl. Pharmacol. 1997, 142:288-296.
97. Wright ES, White DM, Smiler KL Effects of chronic exposure to ozone on pulmonary lipids in rats. Toxicology 1990, 64:313-324.
98. van Bree L, Haagsman HP, van Golde LM, et al. Phosphatidylcholine synthesis in isolated type II pneumocytes from ozone-exposed rats. Arch. Toxicol. 1988, 61:224-228.
99. Haagsman HP, Schuurmans EA, Alink GM, et al. Effects of ozone on phospholipid synthesis by alveolar type II cells isolated from adult rat lung. Exp. Lung Res. 1985, 9:67-84.
100. Haagsman HP, Schuurmans EA, Batenburg JJ, et al. Synthesis of phosphatidylcholines in ozone-exposed alveolar type II cells isolated from adult rat lung: is glycerolphosphate acyltransferase a rate-limiting enzyme?. Exp. Lung Res. 1988, 14:1-17.
101. 2 interfacial transfer is reduced by phospholipid monolayers. J. Appl. Physiol. 2001, 91:2024-2034.
102. Bridges JP, Davis HW, Damodarasamy M, et al. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J. Biol. Chem. 2000, 275:38848-38855.
103. Nachtman JP, Hajratwala BR, Moon HL, et al. Surface-tension measurements of pulmonary lavage from ozone-exposed rats. J. Toxicol. Environ. Health 1986, 19:127-136.
104. Currie WD, van Schaik S, Vargas I, et al. Breathing and pulmonary surfactant function in mice 24 h after ozone exposure. Eur. Respir. J. 1998, 12:288-293.
105. Currie WD, van Schaik SM, Vargas I, et al. Ozone affects breathing and pulmonary surfactant function in mice. Toxicology 1998, 125:21-30.
106. Oosting RS, van Greevenbroek MMJ, Verhoef J, et al. Structural and functional impairment of surfactant protein A induced by ozone. Am. J. Physiol. 1991, 261:L77-L83.
107. Balis JU, Paterson JF, Lundh JM, et al. Ozone stress initiates acute perturbations of secreted surfactant membranes. Am. J. Pathol. 1991, 138:847-857.
108. Oosting RS, Van Iwaarden JF, Van Bree L, et al. Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells. Am. J. Physiol. 1992, 262:L63-L68.
109. Wang G, Umstead TM, Phelps DS, et al. The effect of ozne exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ. Health Perspect. 2002, 110:79-84.
110. Health effects of outdoor air pollution. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Am. J. Respir. Crit. Care Med. 1996, 153:3-50.
111. Su WY, Gordon T Alterations in surfactant protein A after acute exposure to ozone. J. Appl. Physiol. 1996, 80:1560-1567.
112. Griese M, Winzinger G, Schams A, et al. Health effects of sulfur-related environmental air pollution: the pulmonary surfactant system is not disturbed by exposure to acidic sulfate and neutral sulfite aerosols. J. Aerosol Med. 1999, 12:37-44.
113. Lee MM, Green FH, Roth SH, et al. Sulfuric acid aerosol induces changes in alveolar surface tension in the guinea pig but not in the rat. Exp. Lung Res. 1999, 25:229-244.
114. Maier KL, Beck-Speier I, Dayal N, et al. Health effects of sulfur-related environmental air pollution. II. Cellular and molecular parameters of injury. Inhal. Toxicol. 1999, 11:361-369.
115. Plopper CG, Fancchi MV Do urban environmental pollutants exacerbate childhood lung diseases?. Environ. Health Perspect. 2000, 108:A252-A253.
116. Tetley TD, Richards RJ, Harwood JL Changes in pulmonary surfactant and phosphatidylcholine metabolism in rats exposed to chrysotile asbestos dust. Biochem. J. 1977, 166:323-329.
117. Brody AR, Roe MW Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. Am. Rev. Respir. Dis. 1983, 128:724-729.
118. Richards RJ, Curtis CG Biochemical and cellular mechanisms of dust-induced lung fibrosis. Environ. Health Perspect. 1984, 55:393-416.
119. Heppleston AG Pulmonary toxicology of silica, coal and asbestos. Environ. Health Perspect. 1984, 55:111-127.
120. Lewis RW, Harwood JL, Richards RJ The fate of instilled pulmonary surfactant in normal and quartz-treated rats. Biochem. J. 1987, 243:679-685.
121. Miller BE, Hook GE Stimulation of surfactant phospholipid biosynthesis in the lungs of rats treated with silica. Biochem. J. 1988, 253:659-665.
122. Kawada H, Horiuchi T, Shannon JM, et al. Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat. Am. Rev. Respir. Dis. 1989, 140:460-470.
123. Miller BE, Hoo KG Regulation of phosphatidylcholine biosynthesis in activated alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 1989, 1:127-136.
124. Rami J, Stenzel W, Sasic SM, et al. Fatty-acid synthase activity and mRNA level in hypertrophic type II cells from silica-treated rats. Am. J. Physiol. 1994, 267:L128-L136.
125. Spech RW, Wisniowski P, Kachel DL, et al. Surfactant protein A prevents silica-mediated toxicity to rat alveolar macrophages. Am. J. Physiol. 2000, 278:L713-L718.
126. Eskelson CD, Chvapil M, Strom KA, et al. Pulmonary phopholipidosis in rats respiring air containing diesel particulates. Environ. Res. 1984, 44:260-271.
127. Murphy SA, BeruBe KA, Pooley FD, et al. The response of lung epithelium to well characterised fine particles. Life Sci. 1998, 62:1789-1799.
128. Finley TN, Ladman AJ Low yield of pulmonary surfactant in cigarette smokers. N. Engl. J. Med. 1972, 286:223-227.
129. Giammona ST, Tocci P, Webb WR Effects of cigarette smoke on incorporation of radioisotopically labeled palmitic acid into pulmonary surfactant and on surface activity of canine lung extracts. Am. Rev. Respir. Dis. 1971, 104:358-367.
130. Wirtz HR, Schmidt M Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. Eur. Respir. J. 1996, 9:24-32.
131. Cook WA, Webb WR Surfactant in chronic smokers. Ann. Thorac. Surg. 1966, 2:327-333.
132. Subramaniam S, Whitsett JA, Hull W, et al. Alteration of pulmonary surfactant proteins in rats chronically exposed to cigarette smoke. Toxicol. Appl. Pharmacol. 1996, 140:274-280.
133. Honda Y, Takahashi H, Kuroki Y, et al. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996, 109:1006-1009.
134. Xie E, Yang Z, Li A Experimental study on the treatment of smoke inhalation injury with lung lavage and exogenous pulmonary surfactant. Zhonghua Wai Ke Za Zhi 1997, 35:745-748.
135. Lorz C, Lopez J Incidence of air pollution in the pulmonary surfactant system of the pigeon (Columba livia). Anat. Rec. 1997, 249:206.
136. Vincent R, Vu D, Hatch G, et al. Sensitivity of lungs of aging Fischer 344 rats to ozone: assessment by bronchoalveolar lavage. Am. J. Physiol. 1996, 271:L555-L565.
137. Vincent R, Adamson IY Cellular kinetics in the lungs of aging Fischer 344 rats after acute exposure to ozone. Am. J. Pathol. 1995, 146:1008-1016.
138. Matulionis DH Chronic cigarette smoke inhalation and aging in mice: 1. Morphologic and functional lung abnormalities. Exp. Lung Res. 1984, 7:237-256.
139. Iribarren C, Jacobs DR, Sidney S, et al. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest 2000, 117:163-168.
140. Holm BA, Notter RH, Siegle J, et al. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J. Appl. Physiol. 1985, 59:1402-1409.
141. Goad ME, Tryka AF, Witschi HP Surfactant alterations following acute bleomycin and hyperoxia-induced lung damage. Toxicol. Lett. 1986, 32:173-178.
142. Ledwozyw A, Borowicz B The influence of normobaric hyperoxia on lung surfactant phospholipids in rats. Arch. Vet. Pol. 1992, 32:127-133.
143. Holm BA, Matalon S, Finkelstein JN, et al. Type II pneumocyte changes during hyperoxic lung injury and recovery. J. Appl. Physiol. 1988, 65:2672-2678.
144. Kennedy KA, Snyder JM, Stenzel W, et al. Vitamin E alters alveolar type II cell phospholipid synthesis in oxygen and air. Exp. Lung Res. 1990, 16:607-615.
145. Minoo P, King RJ, Coalson JJ Surfactant proteins and lipids are regulated independently during hyperoxia. Am. J. Physiol. 1992, 263:L291-L298.
146. Nogee LM, Wispe JR Effects of pulmonary oxygen injury on airway content of surfactant-associated protein A. Pediatr. Res. 1988, 24:568-573.
147. Nogee LM, Wispe JR, Clark JC, et al. Increased synthesis and mRNA of surfactant protein A in oxygen-exposed rats. Am. J. Respir. Cell Mol. Biol. 1989, 1:119-125.
148. Nogee LM, Wispe JR, Clark JC, et al. Increased expression of pulmonary surfactant proteins in oxygen-exposed rats. Am. J. Respir. Cell Mol. Biol. 1991, 4:102-107.
149. Johnston CJ, Stripp BR, Piedbeouf B, et al. Inflammatory and epithelial responses in mouse strains that differ in sensitivity to hyperoxic injury. Exp. Lung Res. 1998, 24:189-202.
150. Horowitz S, Watkins RH, Auten RL, et al. Differential accumulation of surfactant protein A, B, and C mRNAs in two epithelial cell types of hyperoxic lung. Am. J. Respir. Cell Mol. Biol. 1991, 5:511-515.
151. 2 exposure effects on surfactant protein and mRNA in rat alveolar and bronchiolar epithelium. Am. J. Physiol. 1999, 276:L999-L1009.
152. Liamtsev VG, Arbuzov AA Surfactant system of rat lungs in acute hypoxic hypoxia. Byull Eksp. Biol. Med. 1981, 92:612-614.
153. Prevost MC, Vieu C, Douste Blazy L Hypobaric hypoxia on pulmonary wash fluid of rats. Respiration 1980, 40:76-80.
154. Zaitseva KK, Skorik VI, Shliapnikova SA State of pulmonary surfactant and ultrastructure of the aerohematic barrier in acute hypoxia. Byull. Eksp. Biol. Med. 1981, 92:653-656.
155. Belov GV, Arbuzov AA, Davydov VT Comparative evaluation of the physical methods for studying the pulmonary surfactant system during exposure to acute hypoxia. Byull. Eksp. Biol. Med. 1985, 99:542-545.
156. Chander A, Viswanathan R, Venkitasubramanian TA Effect of acute hypobaric hypoxia on 32-P incorporation into phospholipids of alveolar surfactant, lung, liver and plasma of rat. Environ. Physiol. Biochem. 1975, 5:27-36.
157. Hegde KS, Kumar R, Krishna B, et al. Alveolar macrophages and pulmonary surfactant of altitude-raised rats. Aviat. Space Environ. Med. 1980, 51:700-703.
158. Heath D, Smith P, Harris P Clara cells in the llama. Exp. Cell Biol. 1976, 44:73-82.